Menostar Patch
Product Images NDC 50419-455

12 FDA label images from Bayer Healthcare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Menostar (NDC 50419-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Menostar 01)

Chemical Structure (Menostar 01)
Chemical structure diagram of estradiol, the active ingredient in Menostar transdermal patch. The structure shows characteristic steroid rings and hydroxyl groups, consistent with the molecular structure of estradiol.*
FDA Label Image

Chemical Structure (Menostar 02)

Chemical Structure (Menostar 02)
An illustration diagram showing the cross-sectional layers of a transdermal patch labeled Menostar estradiol 14 micrograms per day. The diagram identifies three layers: (1) Film Backing, (2) Drug/Adhesive Layer, and (3) Protective Liner.*
FDA Label Image

Figure 1 (Menostar 03)

Figure 1 (Menostar 03)
A line graph comparing serum estradiol concentration (pg/mL) over time (hours) between Menostar 14 mcg/day and Clinara 6.5 cm² 25 mcg/day transdermal patches, showing concentration trends with Menostar represented by solid squares and Clinara by open inverted triangles over a 180-hour period.*
FDA Label Image

Figure A (Menostar 04)

Figure A (Menostar 04)
Menostar estradiol transdermal system patch, 14 mcg/day strength. The label indicates each 3.25 cm² system contains 1 mg estradiol USP to deliver 14 mcg estradiol per day. It is for transdermal use only and available by prescription from Bayer HealthCare Pharmaceuticals Inc.*
FDA Label Image

Figure B (Menostar 05)

Figure B (Menostar 05)
An instructional illustration showing the Menostar estradiol transdermal patch packaging. It highlights the top and side tear notches on the foil pouch for easy opening, with a hand peeling the pouch open. The label on the pouch displays Menostar 14 mcg/day, indicating the dosage strength.*
FDA Label Image

Figure C (Menostar 06)

Figure C (Menostar 06)
An illustration of a Menostar transdermal patch showing its shape and labeling. The patch is marked with the brand name "Menostar" in the center and features a protective backing around the edges.*
FDA Label Image

Figure D (Menostar 07)

Figure D (Menostar 07)
Illustration showing hands peeling the protective backing off a Menostar patch, a transdermal estradiol patch. The image labels the 'protective backing' being removed and the 'Menostar patch' itself, demonstrating the application step of the patch.*
FDA Label Image

Figure E (Menostar 08)

Figure E (Menostar 08)
Instructional illustration showing how to carefully remove the Menostar estradiol transdermal patch from its packaging. The image advises not to remove the foil sticker covering the patch while peeling it from the package.*
FDA Label Image

Figure F (Menostar 09)

Figure F (Menostar 09)
An instructional line drawing showing the application of a transdermal patch to the lower abdomen of a person, demonstrating proper placement for the Menostar estradiol patch.*
FDA Label Image

Figure G (Menostar 10)

Figure G (Menostar 10)
An instructional illustration showing a hand applying a round transdermal patch to the lower back or buttocks of a person.*
FDA Label Image

Figure H (Menostar 11)

Figure H (Menostar 11)
An illustration showing a hand applying a round patch to the skin, demonstrating the use of a transdermal patch, likely representing Menostar estradiol patch application instructions.*
FDA Label Image

Menostar Carton (Image 01 2)

Menostar Carton (Image 01 2)
Menostar estradiol transdermal system 14 mcg/day patch packaging label. The box displays product name, strength, dosage form as transdermal system, quantity of 4 systems, and labeling by Bayer HealthCare Pharmaceuticals Inc. The label includes dosing instructions and ingredient information, emphasizing transdermal use only and prescription status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.